Crossmark

3D MALDI mass spectrometry imaging reveals specific localization of long-chain acylcarnitines within a 10-day time window of spinal cord injury

Published Online: 2018-10-31

Authors

Quanico, Jusal

Hauberg-Lotte, Lena

Devaux, Stephanie

Laouby, Zahra

Meriaux, Celine

Raffo-Romero, Antonella

Rose, Melanie

Westerheide, Leia

Vehmeyer, Jost

Rodet, Franck

Maass, Peter

Cizkova, Dasa

Zilka, Norbert

Cubinkova, Veronika

Fournier, Isabelle

Salzet, Michel https://orcid.org/0000-0003-4318-0817
License Information

Text and Data Mining valid from 2018-10-31

Version of Record valid from 2018-10-31
More Information

Article History

Received: 7 June 2018

Accepted: 19 October 2018

First Online: 31 October 2018

Competing Interests

: Peter Maass is on the Advisory Board of SCiLS GmbH, a subsidiary of Bruker Daltonik GmbH, a company that develops and markets software for mass spectrometry imaging. All other authors declare no competing interest.

Document is current